Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pediatric MDS-Associated Germline Mutations in SAMD9 and SAMD9L Impair Multiple Pathways in Primary Hematopoietic Cells

ABSTRACT: Pediatric MDS-Associated Germline Mutations in SAMD9 and SAMD9L Impair Multiple Pathways in Primary Hematopoietic Cells

PROVIDER: PRJNA639279 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12007938_1.fastq.gz	Fastqsanger.gz
	SRR12007938_2.fastq.gz	Fastqsanger.gz
	SRR12007939_1.fastq.gz	Fastqsanger.gz
	SRR12007939_2.fastq.gz	Fastqsanger.gz
	SRR12007940_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

Pediatric MDS-Associated Germline Mutations in SAMD9 and SAMD9L Impair Multiple Pathways in Primary Hematopoietic Cells

Project description:Here, we used a lentiviral over-expression approach to assess the functional impact and underlying cellular processes of wild-type and mutant SAMD9 or SAMD9L in primary mouse or human hematopoietic stem and progenitor cells (HSPC). Using a combination of protein interactome analyses, transcriptional profiling and functional validation, we found that SAMD9 and SAMD9L are multifunctional proteins that cause profound alterations in cell cycle, protein translation, and proliferation of HSPCs. Importantly, our molecular and functional studies also demonstrated that expression of these genes and their mutations leads to a toxic cellular environment that promotes DNA-damage repair defects and ultimately lead to apoptosis in hematopoietic cells. This study provides novel functional insights into SAMD9 and SAMD9L and how their mutations can potentially alter hematopoietic function and lead to bone marrow hypocellularity, a hallmark of pediatric MDS.

2020-11-30 | GSE152420 | GEO

Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.

Project description:Pediatric myelodysplastic syndromes (MDS) are a heterogeneous disease group associated with impaired hematopoiesis, bone marrow hypocellularity, and frequently have deletions involving chromosome 7 (monosomy 7). We and others recently identified heterozygous germline mutations in SAMD9 and SAMD9L in children with monosomy 7 and MDS. We previously demonstrated an antiproliferative effect of these gene products in non-hematopoietic cells, which was exacerbated by their patient-associated mutations. Here, we used a lentiviral overexpression approach to assess the functional impact and underlying cellular processes of wild-type and mutant SAMD9 or SAMD9L in primary mouse or human hematopoietic stem and progenitor cells (HSPC). Using a combination of protein interactome analyses, transcriptional profiling, and functional validation, we show that SAMD9 and SAMD9L are multifunctional proteins that cause profound alterations in cell cycle, cell proliferation, and protein translation in HSPCs. Importantly, our molecular and functional studies also demonstrated that expression of these genes and their mutations leads to a cellular environment that promotes DNA damage repair defects and ultimately apoptosis in hematopoietic cells. This study provides novel functional insights into SAMD9 and SAMD9L and how their mutations can potentially alter hematopoietic function and lead to bone marrow hypocellularity, a hallmark of pediatric MDS.

| S-EPMC8446103 | biostudies-literature

Gene expression profiling of pediatric myelodysplastic syndrome (MDS) characterizes disease subtype and time to progression into acute myeloid leukemia (AML)

Project description:Identification of relevant subgroups in childhood MDS patients by gene expression analysis and gene involve in progression into AML Class comparison between different subgroups of pediatric MDS (class risk, classification subtype)

2012-02-29 | E-GEOD-29326 | biostudies-arrayexpress

Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma

Project description:Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma

| PRJNA683103 | ENA

Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma

Project description:Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma

| PRJNA683104 | ENA

Dysregulated gene expression pathways in mice models of HR-MDS and AML post MDS mimic human disease

Project description:In spite of the recent discovery of genetic mutations in most MDS, pathophysiology of those disorders remain poorly known, and few animal are available. We performed global exome specific gene expression profiling and functional pathway analysis in purified Sca1+ spleen cells of two MDS transgenic mouse models developed by our group. Those models mimic high-risk MDS (HR MDS) and AML post MDS, depending on the transgene promoters used (MRP8NRASD12/tethBCL-2 and MRP8NRASD12/MRP8hBCL-2 respectively). We found common deregulated pathways in both models showing disease continuum. The most significantly deregulated pathways identified have previously been reported in MDS patients such as cell cycle, DNA replication/damage/repair, apoptosis, immune responses and canonical Wnt pathways. Interestingly, this analysis highlights other deregulated pathways such as non-canonical Wnt pathways including Rho signaling and circadian rhythm that may be critical in a human MDS setting.

2017-02-11 | GSE72934 | GEO

Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS/AML

Project description:Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS/AML

| PRJNA815671 | ENA

Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation

Project description:Despite relevant clinical and/or familial presentations suggesting a hereditary predisposition (early-onset, multiple primary tumors, familial aggregation), targeted genomic analysis based on the phenotype are often non contributive. As somatic cancer genes are limited, the hypothesis is that the targeted next-generation sequencing of 200 genes, selected for their implications in cancers may contribute to the understanding of many selected patients’ presentation by the identification of germline deleterious mutations, and may identified phenotype overlapping and/or mosaicisms. The focus will be put on early-onset breast, ovarian, colorectal cancer or pediatric cancers and multiple primary tumors.

| 2206884 | ecrin-mdr-crc

ARST17B2-Q Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma

Project description:ARST17B2-Q Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma

| PRJNA931428 | ENA

ARST17B2-Q Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma

Project description:ARST17B2-Q Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma

| PRJNA931427 | ENA